Although the pathogenesis of skeletal resistance and the contributing factors remain unclear, the action of TGF-β on bone and/or osteoblasts may be involved in PTH resistance in CKD conditions such as the accumulation of uremic toxins [95,96,97]. Here, TGFB1 is linked to chronic kidney disease.